Vancouver, British Columbia — September 3, 2026 — Leads & Copy — Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF), formerly a non-revenue issuer, has transitioned into a revenue-producing consumer packaged goods (CPG) business following the acquisition of Holy Crap Foods Inc. on February 26, 2026. The company reported its financial and operating results for the three and six months ended June 30, 2026, indicating significant revenue growth and maintained product margins.
For the first half of 2026, Restart Life Sciences generated $465,715 in total revenue, a substantial increase from $Nil in the same period of 2025. The second quarter of 2026 saw revenue reach $331,162, representing a 146% sequential increase from the first quarter of 2026, attributed to the integration of Holy Crap’s operations.
The Holy Crap brand contributed approximately $110,000 in revenue in June 2026, with gross margins around 35%. This marks a 64.2% year-over-year increase for the brand, driven by sales across wholesale, distribution, and e-commerce channels. Overall gross profit for Q2 2026 was $130,699, yielding a 39.5% gross margin. For the first half of the year, the gross profit was $192,636, with an overall gross margin of 41.4%.
The company’s balance sheet showed a total asset base of $1,903,647 as of June 30, 2026, an increase from $1,767,208 at the end of 2025. Shareholders’ Equity stood at $1,324,748.
“Our management team remains focused on strategic growth, revenue generation, and market expansion,” said Steve Loutskou, CEO of Restart Life. “Transitioning from a non-revenue issuer a year ago to reporting $465,715 in revenue for the first half of 2026 reflects the initial integration of our operations. With our presence on digital platforms, our entry into the U.S. market via Amazon, and our evaluation of potential M&A opportunities, we continue to execute our business plan, though we recognize the ongoing costs, capital requirements, and operational risks necessary to scale the business over the long term.”
Key operational initiatives advanced during and after the second quarter include securing a listing for Holy Crap on Walmart Canada’s online marketplace, Walmart.ca, announced April 28, 2026. The company also entered the U.S. market through Amazon USA on May 13, 2026, and launched a multi-month market pilot in the Caribbean on June 10, 2026, to assess international demand.
In product development, Restart Life Sciences has commenced commercial production of a new protein-focused product line following collaboration with the University of Manitoba’s Richardson Centre for Food Technology and Research. The company is also developing specific formulations for youth and senior consumer segments.
The company is integrating AI-driven tools and customer relationship management platforms to enhance online sales, customer engagement, and operational efficiency. Management is also evaluating targeted merger and acquisition opportunities in the health and CPG sectors, seeking established, revenue-generating businesses that complement its existing infrastructure.
Restart Life Sciences Corp. is a Canadian-based life sciences company listed on the CSE. Holy Crap Superseed Cereal and Holy Crap Superseed Oatmeal are premium functional food brands offering nutrient-dense, clean-label products. Based in Gibsons, British Columbia, the brand offers gluten-free, non-GMO, high-fiber products that support digestive health and sustained energy.
Source: Restart Life Sciences Corp.
